Advertisement

Primäre Krankheiten des Lungenparenchyms

  • P. Birrer
  • H. Lindemann
  • F. Brasch
  • K.-M. Müller
  • N. Teig
  • H. von der Hardt
Chapter
  • 16 Downloads

Zusammenfassung

Die interstitiellen Pneumopathien sind eine ätiologisch heterogene Gruppe von Lungenkrankheiten (Übersicht 12.1), die sich klinisch, radiologisch und lungenphysiologisch ähnlich manifestieren. Im Verlauf können sie sich sehr unterschiedlich präsentieren, ihr gemeinsames Ende finden sie in einer mehr oder weniger ausgeprägten Lungenfibrose, die sich aber in ihrem Endstadium — sei das nach (Defekt-)Heilung oder terminal in der schweren Lungenfibrose — nicht mehr ätiopathogenetisch differenzieren lässt. Während die Diagnose einer interstitiellen Pneumopathie recht einfach gestellt werden kann, verlangt die ätiologische Zuordnung die Interpretation der Anamnese, der klinischen Manifestation und von vielen Einzeluntersuchungen und setzt hohes fachliches Wissen und Erfahrung voraus. Die meisten interstitiellen Pneumopathien sind selten, insbesondere im Kindesalter. Untersuchungstechniken und Behandlungsstrategien werden deshalb von den Erwachsenen übernommen.

Literatur

  1. Chetty A, Bhuyan UN, Mitra DK et al. (1987) Cryptogenic fibrosing alveolitis in children. Ann Allergy 58:336PubMedGoogle Scholar
  2. Crystal RG, Gadek JE, Ferrans VJ et al. (1981) Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 85:769Google Scholar
  3. Demendts M, Wells AU, Anto JM et al (2001) Interstitial lung disease: an epidemiological overview. Eur Respir J 18 (Suppl 32) : 2s–16sGoogle Scholar
  4. Du Bois RM and Wells AU (2001) Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis. Eur Respi J 18 (Suppl 32):43s–55sGoogle Scholar
  5. Hewitt CJ, Hull D, Keeling JW (1977) Fibrosing alveolitis in infancy and childhood. Arch Dis Child 52:22CrossRefPubMedGoogle Scholar
  6. Müller NL, Staples CA, Miller RR et al. (1987) Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 165:731PubMedGoogle Scholar
  7. Osika E, Muller MH, Boccon-Gibod L et al. (1997) Idiopathic pulmonary fibrosis in infants. Pediatr Pulmonol 23(1):49–54CrossRefPubMedGoogle Scholar
  8. Stillwell P, Norris DG, O’Connell EJ et al. (1980) Desquamative pneumonitis in children. Chest 77:165CrossRefPubMedGoogle Scholar
  9. Tal A, Maor E, Bar-Ziv J, Gorodischer R (1984) Fatal desquamative in-terstital pneumonia in three infant siblings. J Pediatr 104:873CrossRefPubMedGoogle Scholar
  10. Wolff G, Crystal RG (1997) Biology of pulmonary fibrosis. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations, 2nd edn. Lippincott-Raven, Philadelphia, pp 2509–2524Google Scholar
  11. Zapletal A, Houstek J, Samanek M, Paul T (1985) Lung function in children and adolescents with idiopathic interstitial pulmonary fibrosis. Pediatr Pulmonol 1:154CrossRefPubMedGoogle Scholar
  12. Bertorelli G, Bocchino V, Olivieri D (2000) Hypersensitivity pneumonitis. Eur Respir Mon 14:120–136Google Scholar
  13. Bourke SJ, Dalphin JC, Boyd G et al. (2001) Hypersinsitivity pneumonitis: current concepts. Eur Respir J 18 (Suppl 32): 81s–92sGoogle Scholar
  14. Deutsche Gesellschaft für Pneumologie (1993) Empfehlungen zum diagnostischen Vorgehen bei diffusen Lungenkrankheiten. Pneumologie 47:473–478Google Scholar
  15. Lindemann H, Keller F, Velcovsky HG (1982) Exogene allergische Alveolitis im Kindesalter. Ergeb Inn Med Kinderheilkd 50:1–30PubMedGoogle Scholar
  16. Satake N, Nagai S, Kawatani A et al. (1993) Density of phenotypic markers on BAL T-lymphocytes in hypersensitivity pneumonitis, pulmonary sarcoidosis and bronchiolitis obliterans with organizing pneumonia. Eur Respir J 6:477–482PubMedGoogle Scholar
  17. Sennekamp HJ (1999) Exogene-allergische Alveolitis. In: Schultze-Weninghaus G, Fuchs T, Bachert C, Wahn U (Hrsg) Manuale aller-gologicum V9, pp 1 – 68Google Scholar
  18. Yee WFH, Castile RG, Cooper A et al. (1990) Diagnosing bird fancier’s disease in children. Pediatrics 85:848–852PubMedGoogle Scholar
  19. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ (2002) Autoantibodies against granulocyte macrophage colony stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 27(4):481 – 486CrossRefPubMedGoogle Scholar
  20. Brown AP, Chang D, Rust K, Crouch EC (1996) Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion. J Biol Chem 271(31):18912–18919CrossRefGoogle Scholar
  21. Cardoso WV, Itoh A, Nogawa H, Mason I, Brody JS (1997) FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium. Dev Dyn 208(3):398–405CrossRefPubMedGoogle Scholar
  22. Carraway MS, Ghio AJ, Carter JD, Piantadosi CA (2000) Detection of granulocyte. Macrophage colony stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 161(4 Pt 1):1294–1299CrossRefPubMedGoogle Scholar
  23. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE et al. (1995) Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 92(17):7794–7798CrossRefPubMedGoogle Scholar
  24. Davidson JM, Macleod WM (1969) Pulmonary alveolar proteinosis. Br J Dis Chest 63(1):13–28CrossRefPubMedGoogle Scholar
  25. Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R et al. (1997) Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest, 100(9):2211 – 2217CrossRefPubMedGoogle Scholar
  26. Dirksen U, Moritz T, Burdach S, Flasshove M, Hanenberg H (1999) Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches. Klin Padiatr 211(4): 329–335CrossRefPubMedGoogle Scholar
  27. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT et al. (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264(5159): 713–716CrossRefPubMedGoogle Scholar
  28. Dranoff G, Mulligan RC (1994) Activities of granulocyte macrophage colony stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells 12 (Suppl 1) : 173 – 182PubMedGoogle Scholar
  29. Griese M, Tredano M, Nicolai M, Bahuau M (2002) Molekulare Grundlagen und Klinik der pulmonalen Alveolarproteinosen. Dtsch Ärztebl 99(15):1013–1023Google Scholar
  30. Hamvas A, Cole FS, deMello DE, Moxley M, Whitsett JA, Colten HR et al. (1994) Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr 125(3):356–361CrossRefPubMedGoogle Scholar
  31. Hamvas A, Nogee LM, Mallory-GB J, Spray TL, Huddieston CB, August A et al. (1997) Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130(2):231–239CrossRefPubMedGoogle Scholar
  32. Hamvas A, Nogee LM, deMello DE, Cole FS (1995) Pathophysiology and treatment of surfactant protein-B deficiency. Biol Neonate 67 (Suppl 1):18–31CrossRefPubMedGoogle Scholar
  33. Katzenstein AL, Gordon LP, Oliphant M, Swender PT (1995) Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 19(4):439–447CrossRefPubMedGoogle Scholar
  34. Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK (2000) Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 161(4 Pt 1):1143–1148CrossRefPubMedGoogle Scholar
  35. Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y et al. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte macrophage colony stimulating factor. J Exp Med 190(6): 875–880CrossRefPubMedGoogle Scholar
  36. Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y et al. (2000) Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 162(2 Pt 1) :658–662CrossRefPubMedGoogle Scholar
  37. Mahut B, Delacourt C, Scheinmann P, De Blic J, Mani TM, Fournet JC et al. (1996) Pulmonary alveolar proteinosis: experience with eight pediatric cases and a review. Pediatrics 97(1): 117–122PubMedGoogle Scholar
  38. Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T et al. (1995) Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor- deficient mice are normal. Immunity 2(3): 211–222CrossRefPubMedGoogle Scholar
  39. Nogee LM, de Mello DE, Dehner LP, Colten HR (1993) Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 328(6):406–410CrossRefPubMedGoogle Scholar
  40. Nogee LM, Gamier G, Dietz HC, Singer L, Murphy AM, deMello DE et al. (1994) A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93(4): 1860 – 1863CrossRefPubMedGoogle Scholar
  41. Nogee LM (1997) Surfactant protein-B deficiency. Chest 111 (Suppl 6):129S-135SCrossRefGoogle Scholar
  42. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA (2000) Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 161(3 Pt 1):973–981CrossRefPubMedGoogle Scholar
  43. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA (2001) A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344(8): 573–579CrossRefPubMedGoogle Scholar
  44. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM (1987) Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 62(6): 499–518CrossRefPubMedGoogle Scholar
  45. Rosen SH, Castleman B, Liebow AA (1958) Pulmonary Alveolar Proteinosis. N Engl J Med 258(23): 1123 – 1142CrossRefPubMedGoogle Scholar
  46. Ruano ML, Perez GJ, Casals C (1998) Effect of acidic pH on the structure and lipid binding properties of porcine surfactant protein A. Potential role of acidification along its exocytic pathway. J Biol Chem 273(24):15183–15191CrossRefPubMedGoogle Scholar
  47. Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR et al. (2001) Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 163(2):524–531CrossRefPubMedGoogle Scholar
  48. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years (2002) Am J Respir Crit Care Med 166(2): 215–235Google Scholar
  49. Tanaka N, Watanabe J, Kitamura T, Yamada Y, Kanegasaki S, Nakata K (1999) Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 442(2–3):246–250CrossRefPubMedGoogle Scholar
  50. Thomas AQ, Lane K, Phillips J, III, Prince M, Markin C, Speer M et al. (2002) Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165(9): 1322 – 1328CrossRefPubMedGoogle Scholar
  51. Wallot M, Wagenvoort C, deMello D, Muller KM, Floros J, Roll C (1999) Congenital alveolar proteinosis caused by a novel mutation of the surfactant protein B gene and misalignment of lung vessels in consanguineous kindred infants. Eur J Pediatr 158(6): 513 – 518CrossRefPubMedGoogle Scholar
  52. Case report of the Massachusetts General Hospital (1993) Case 16–1993. N Engl J Med 328:1183–1190CrossRefGoogle Scholar
  53. Cutz E (1987) Idiopathic pulmonary hemosiderosis and related disorders in infancy and childhood. Perspect Pediatr Pathol 11:47–81PubMedGoogle Scholar
  54. Dearborn DG (1997) Pulmonary hemorrhage in infants and children. Curr Opin Pediatr 9:219–224CrossRefPubMedGoogle Scholar
  55. Dearborn DG, Smith PG, Dahms BB et al. (2002) Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland. Pediatrics 110:627–637CrossRefPubMedGoogle Scholar
  56. Elidemir O, Colasurdo GN, Rossmann SN, Fan LL (1999) Isolation of Stachybotrys from the lung of a child with pulmonary hemosiderosis. Pediatrics 964–966Google Scholar
  57. Etzel RA, Montana E, Sorenson WG et al. (1998) Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152:757 – 762CrossRefPubMedGoogle Scholar
  58. Heiner DC, Sears JW, Kniker WT (1962) Multiple precipitins to cow’s milk in chronic respiratory disease. Am J Dis Child 103:634–654PubMedGoogle Scholar
  59. Jennings CA, King TE, Juder R et al. (1997) Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 155:1101 – 1109CrossRefPubMedGoogle Scholar
  60. Müller KM, Fenyves A (1991) Pleuraveränderungen und Überblick über die idiopathische Lungenhämosiderose (Ceelen-Gellerstedt-Erkrankung). Pneumologie 45:23 – 30PubMedGoogle Scholar
  61. Ploier R, Emhofer J, Dorniger L et al. (1998) Immunologische Aspekte bei idiopathischer Lungenhämosiderose und Zoeliakie. Klin Pädiatr 209:409–412CrossRefGoogle Scholar
  62. Rossi GA, Balzano E, Battistini E et al. (1992) Long term prednisone and azathioprine treatment of a patient with idiopathic pulmonary hemosiderosis. Pediatr Pulmonol 13:176–180CrossRefPubMedGoogle Scholar
  63. Saeed MM, Woo MS, MacLoughlin EF et al. (1999) Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest 116:721 – 725CrossRefPubMedGoogle Scholar
  64. Torres MJ, Girón MD, Corzo JL et al. (1996) Release of inflammatory mediators after cow’s milk intake in a newborn with idiopathic pulmonary hemosiderosis. J Allergy Clin Immunol 98:1120–1123CrossRefPubMedGoogle Scholar
  65. Castellana G, Gentile M, Castellana R, Fiorente P, Lamorgese V (2002) Pulmonary alveolar microlithiasis: Clinical features, evolution of the phenotype and review of the literature. Am J Med Genet 111: 220–224CrossRefPubMedGoogle Scholar
  66. Jackson KB, Modry DL, Halenar J et al. (2001) Single lung transplantation for pulmonary alveolar microlithiasis. J Heart Lung Transplant 20:226CrossRefPubMedGoogle Scholar
  67. Korn MA, Schurawitzki H, Klepetko W, Burghuber OC (1992) Pulmonary alveolar microlithiasis: findings on high-resolution CT. Am J Roentgenol 158:981CrossRefGoogle Scholar
  68. Ozcelik U, Gulsun M, Gocmen A et al. (2002) Treatment and follow-up of pulmonary alveolar microlithiasis with disodium editronate: radiological demonstration. Pediatr Radiol 32:380–383CrossRefPubMedGoogle Scholar
  69. Ratjen FA, Schoenfeld B, Wiesemann HG (1992) Pulmonary alveolar microlithiasis and interstitial pneumonitis in a ten year old girl. Eur Respir J 5:1283PubMedGoogle Scholar
  70. Schmidt H, Lörchner U, Kitz R et al. (1996) Pulmonary alveolar microlithiasis in children. Pediatr Radiol 26:33CrossRefPubMedGoogle Scholar
  71. Ucan ES, Keyf AL, Aydilek R et al. (1993) Pulmonary alveolar microlithiasis: review of Turkish reports. Thorax 48:171CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • P. Birrer
  • H. Lindemann
  • F. Brasch
  • K.-M. Müller
  • N. Teig
  • H. von der Hardt

There are no affiliations available

Personalised recommendations